Efficacy of recombinant canine distemper virus expressing Leishmania antigen against Leishmania challenge in dogs

PLoS Neglected Tropical Diseases

Volumn 9, Issue 7, 2015, Pages

  Miura, Ryuichi ^a   Kooriyama, Takanori ^a,c   Yoneda, Misako ^a   Takenaka, Akiko ^a,d   Doki, Miho ^a   Goto, Yasuyuki ^a   Sanjoba, Chizu ^a   Endo, Yasuyuki ^a,b   Fujiyuki, Tomoko ^a   Sugai, Akihiro ^a   Tsukiyama Kohara, Kyoko ^b   Matsumoto, Yoshitsugu ^a   Sato, Hiroki ^a   Kai, Chieko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c RAKUNO GAKUEN UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; INTERLEUKIN 12; LEISHMANIA ANTIGEN; MEASLES VACCINE; UNCLASSIFIED DRUG; PARASITE ANTIGEN; PROTOZOAL VACCINE; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANINE DISTEMPER; CANINE DISTEMPER VIRUS; CONTROLLED STUDY; DOG; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOBLOTTING; LEISHMANIA MAJOR; LEISHMANIASIS; NONHUMAN; PROTEIN EXPRESSION; VIRUS STRAIN; ANIMAL; GENE VECTOR; GENETICS; IMMUNOLOGY; LEISHMANIASIS, CUTANEOUS; METABOLISM; PARASITOLOGY;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, PROTOZOAN; DISTEMPER VIRUS, CANINE; DOGS; FEMALE; GENETIC VECTORS; HUMANS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; PROTOZOAN VACCINES; VIRAL VACCINES;

EID: 84938650834     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003914     Document Type: Article

References (47)

1. Herwaldt BL (1999) Leishmaniasis. Lancet 354: 1191–1199.
2. World Health Organization. Leishmaniasis. http://wwwwhoint/leishmaniasis/burden/magnitude/burden_magnitude/en/indexhtml.
3. Zerpa O, Ulrich M, Negron E, Rodriguez N, Centeno M, Rodriguez V, et al. (2000) Canine visceral leishmaniasis on Margarita Island (Nueva Esparta, Venezuela). Transactions of the Royal Society of Tropical Medicine & Hygiene 94: 484–487.
4. Dietze R, Barros GB, Teixeira L, Harris J, Michelson K, Falqueto A, et al. (1997) Effect of eliminating seropositive canines on the transmission of visceral leishmaniasis in Brazil. Clinical Infectious Diseases 25: 1240–1242. PMID: 9402389
5. Gradoni L (2001) An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine. Veterinary Parasitology 100: 87–103. PMID: 11522409
6. Kobets T, Grekov I, Lipoldova M (2012) Leishmaniasis: prevention, parasite detection and treatment. Current Medicinal Chemistry 19: 1443–1474. PMID: 22360481
7. Das A, Ali N (2012) Vaccine Development Against Leishmania donovani. Frontiers in Immunology 3: doi: 10.3389/fimmu.2012.00099
8. Palatnik-de-Sousa CB (2008) Vaccines for leishmaniasis in the fore coming 25 years. Vaccine 26: 1709–1724. doi: 10.1016/j.vaccine.2008.01.023 PMID: 18295939
9. Kedzierski L (2010) Leishmaniasis Vaccine: Where are We Today? Journal of Global Infectious Diseases 2: 177–185. doi: 10.4103/0974-777X.62881 PMID: 20606974
10. Pirmez C, Marzochi MC, Coutinho SG (1988) Experimental canine mucocutaneous leishmaniasis (Leishmania braziliensis braziliensis). Memorias do Instituto Oswaldo Cruz 83: 145–151. PMID: 2687621
11. Cruz-Chan J, Aguilar-Cetina Adel C, Villanueva-Lizama L, Martínez-Vega P, Ramírez-Sierra M, Rosado-Vallado ME, et al. (2014) A canine model of experimental infection with Leishmania (L.) mexicana. Parasites & Vectors 7: doi: 10.1186/1756-3305-1187-1361
12. Appel MJ (1969) Pathogenesis of canine distemper. American Journal of Veterinary Research 30: 1167–1182. PMID: 4894003
13. Blixenkrone-Moller M, Svansson V, Have P, Orvell C, Appel M, Pedersen IR, et al. (1993) Studies on manifestations of canine distemper virus infection in an urban dog population. Veterinary Microbiology 37: 163–173. PMID: 8296445
14. Calderon MG, Remorini P, Periolo O, Iglesias M, Mattion N, La Torre J. (2007) Detection by RT-PCR and genetic characterization of canine distemper virus from vaccinated and non-vaccinated dogs in Argentina. Veterinary Microbiology 125: 341–349. PMID: 17628358
15. Ek-Kommonen C, Sihvonen L, Pekkanen K, Rikula U, Nuotio L (1997) Outbreak off canine distemper in vaccinated dogs in Finland. Veterinary Record 141: 380–383. PMID: 9364705
16. Haas L, Martens W, Greiser-Wilke I, Mamaev L, Butina T, Maack D, et al. (1997) Analysis of the haemagglutinin gene of current wild-type canine distemper virus isolates from Germany. Virus Research 48: 165–171. PMID: 9175255
17. Jozwik A, Frymus T (2002) Natural distemper in vaccinated and unvaccinated dogs in Warsaw. Journal of Veterinary Medicine Series B 49: 413–414. PMID: 12489707
18. Simon-Martinez J, Ulloa-Arvizu R, Soriano VE, Fajardo R (2008) Identification of a genetic variant of canine distemper virus from clinical cases in two vaccinated dogs in Mexico. Veterinary Journal 175: 423–426.
19. Iwatsuki K, Miyashita N, Yoshida E, Gemma T, Shin YS, Mori T, et al. (1997) Molecular and phylogenetic analyses of the haemagglutinin (H) proteins of field isolates of canine distemper virus from naturally infected dogs. Journal of General Virology 78: 373–380. PMID: 9018060
20. Takenaka A, Yoneda M, Seki T, Uema M, Kooriyama T, Nishi T, et al. (2014) Characterization of two recent Japanese field isolates of canine distemper virus and examination of the avirulent strain utility as an attenuated vaccine. Veterinary Microbiology 174: 372–381. doi: 10.1016/j.vetmic.2014.10.024 PMID: 25465179
21. Fujita K, Miura R, Yoneda M, Shimizu F, Sato H, Muto Y, et al. (2007) Host range and receptor utilization of canine distemper virus analyzed by recombinant viruses: Involvement of heparin-like molecule in CDV infection. Virology 359: 324–335. PMID: 17055025
22. Webb JR, Campos-Neto A, Ovendale PJ, Martin TI, Stromberg EJ, Badaro R, et al. (1998) Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family. Infection & Immunity 66: 3279–3289.
23. Campos-Neto A, Porrozzi R, Greeson K, Coler RN, Webb JR, Seiky YA, et al. (2001) Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease. Infection & Immunity 69: 4103–4108.
24. Webb JR, Kaufmann D, Campos-Neto A, Reed SG (1996) Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis. Journal of Immunology 157: 5034–5041.
25. Mendez S, Belkaid Y, Seder RA, Sacks D (2002) Optimization of DNA vaccination against cutaneous leishmaniasis. Vaccine 20: 3702–3708. PMID: 12399198
26. Ahmed SB, Touihri L, Chtourou Y, Dellagi K, Bahloul C (2009) DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice. Vaccine 27: 99–106. doi: 10.1016/j.vaccine.2008.10.013 PMID: 18951941
27. Kobune F, Sakata H, Sugiura A (1990) Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. Journal of Virology 64: 700–705. PMID: 2153236
28. Gemma T, Watari T, Akiyama K, Miyashita N, Shin YS, Iwatsuki K, et al. (1996) Epidemiological observations on recent outbreaks of canine distemper in Tokyo area. Journal of Veterinary Medical Science 58: 547–550. PMID: 8811624
29. Okuno T, Goto Y, Matsumoto Y, Otsuka H, Matsumoto Y (2003) Applications of recombinant Leishmania amazonensis expressing egfp or the beta-galactosidase gene for drug screening and histopathological analysis. Experimental Animals 52: 109–118.
30. Manna L, Reale S, Viola E, Vitale F, Foglia-Manzillo V, Pavone LM, et al. (2006) Leishmania DNA load and cytokine expression levels in asymptomatic naturally infected dogs. Vet Parasitol 142: 271–280. PMID: 16920264
31. Carrillo E, Ahmed S, Goldsmith-Pestana K, Nieto J, Osorio Y, Travi B, et al. (2007) Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis. Vaccine 25: 1534–1543. PMID: 17178178
32. Reis AB, Giunchetti RC, Carrillo E, Martins-Filho OA, Moreno J (2010) Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis. Trends in Parasitology 26: 341–349. doi: 10. 1016/j.pt.2010.04.005 PMID: 20488751
33. Poot J, Rogers ME, Bates PA, Vermeulen A (2005) Detailed analysis of an experimental challenge model for Leishmania infantum (JPC strain) in dogs. Veterinary Parasitology 130: 41–53. PMID: 15893068
34. Nogueira FS, Moreira MA, Borja-Cabrera GP, Santos FN, Menz I, Parra LE,. et al. (2005) Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs. Vaccine 23: 4805–4810. PMID: 16011864
35. Saraiva EM, de Figueiredo Barbosa A, Santos FN, Borja-Cabrera GP, Nico D, Souza LO, et al. (2006) The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine. Vaccine 24: 2423–2431. PMID: 16386824
36. Kemp K (2000) Cytokine-producing T cell subsets in human leishmaniasis. Archivum Immunologiae et Therapiae Experimentalis 48: 173–176. PMID: 10912621
37. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM (1989) Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. Journal of Experimental Medicine 169: 59–72. PMID: 2521244
38. Locksley RM, Scott P (1991) Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function. Immunology Today 12: A58–61. PMID: 1829891
39. Scott P, Natovitz P, Coffman RL, Pearce E, Sher A (1988) Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. Journal of Experimental Medicine 168: 1675–1684. PMID: 2903212
40. Dinarello CA, Novick D, Puren AJ, Fantuzzi G, Shapiro L, Muhl H, et al. (1998) Overview of interleukin- 18: more than an interferon-gamma inducing factor. Journal of Leukocyte Biology 63: 658–664. PMID: 9620656
41. Trinchieri G, Gerosa F (1996) Immunoregulation by interleukin-12. Journal of Leukocyte Biology 59: 505–511. PMID: 8613697
42. Gracie JA, Robertson SE, McInnes IB (2003) Interleukin-18. Journal of Leukocyte Biology 73: 213–224. PMID: 12554798
43. O'Donovan LH, McMonagle EL, Taylor S, Bain D, Pacitti AM, Golder MC, et al. (2005) A vector expressing feline mature IL-18 fused to IL-1beta antagonist protein signal sequence is an effective adjuvant to a DNA vaccine for feline leukaemia virus. Vaccine 23: 3814–3823. PMID: 15893619
44. Suo S, Ren Y, Li G, Zarlenga D, Bu RE, Su D, et al. (2012) Immune responses induced by DNA vaccines bearing Spike gene of PEDV combined with porcine IL-18. Virus Research 167: 259–266. doi: 10.1016/j.virusres.2012.05.007 PMID: 22643071
45. Siva Reddy K, Muralidhar Rao D, Badrinaryana N, Suryanaryana VV, Reddy GR (2010) Enhancement of DNA vaccine (P12A3C-pcDNA) efficacy against foot-and-mouth disease by coadministration of interleukin- 18-expressing (IL18 pcDNA) plasmid in guinea-pigs. FEMS Immunology & Medical Microbiology 60: 261–269.
46. Shen G, Jin N, Ma M, Jin K, Zheng M, Zhuang T, et al. (2007) Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18. Vaccine 25: 4193–4202. PMID: 17418456
47. Liu Y, Sato H, Hamana M, Moonan N, Yoneda M, Xia X, et al. (2014) Construction of an expression system for bioactive IL-18 and generation of recombinant canine distemper virus expressing IL-18. Journal of Veterinary Medical Science 76: 1241–1248. PMID: 24898077